Last updated on October 2017

Efficacy Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)

Brief description of study

Multi-center, double-masked randomized, efficacy, safety and pharmacokinetic (PK) study.

Detailed Study Description

Primary: Describe the efficacy of 0.25% and 0.5% topical timolol maleate GFS as assessed through IH changes in color. Secondary: Describe the safety and PK of topical timolol maleate GFS for treatment of IH.

Clinical Study Identifier: NCT02913612


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Sarah Chamlin, MD

Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, IL United States
  Connect »

Anita Haggstrom, MD

Indiana University Health
Indianapolis, IN United States
  Connect »

Kate Puttgen, MD

Johns Hopkins Medical Center
Baltimore, MD United States
  Connect »

Marilyn Liang, MD

Boston Children's Hospital
Boston, MA United States
  Connect »

Megha Tollefson, MD

Mayo Clinic
Rochester, MN United States
  Connect »

Maria Garzon, MD

Columbia University Medical Center
New York, NY United States
  Connect »

Adrienne Hammill, MD

Cincinnati Children's Hospital Medical Center
Cincinnati, OH United States
  Connect »

Jenna Streicher, MD

Children's Hospital of Philadephia
Philadelphia, PA United States
  Connect »

Adelaide Hebert, MD

The University of Texas Medical School at Houston
Houston, TX United States
  Connect »

Beth Drolet, MD

Medical College of Wisconsin
Milwaukee, WI United States
  Connect »